-$1,172 Loss
CLSNLong Stock
Entry comments: Long position for good news in July.
Exit comments: CLSN was a no-go on their liver cancer drug results. The bad news caused the stock to tank. Glad I played this one small and learned about how biotech can run up in anticipation of good news.
Newsletters:SuperNova Alerts
Broker:ETrade
Join Now
| Date | Price | |
|---|---|---|
| Entry | 6/16/2020 | 3.99 |
| Exit | 7/16/2020 | 1.06 |
- Total Views215
- Position Size400
- Percentage-73.43%
Copy and paste the following into your page or blog. If using WordPress, you must paste this in the HTML tab only:
